Cytokine and chemokine dysregulation in hyper-IgE syndrome

Clin Immunol. 2001 Jul;100(1):49-56. doi: 10.1006/clim.2001.5039.

Abstract

Hyper-IgE syndrome is characterized by severe recurrent staphylococcal infections, eczema, bone abnormalities, and markedly elevated levels of immunoglobulin E (IgE). The genetic basis is not known and the central immunologic defect is largely undefined. Reduced neutrophil chemotaxis is often described, and variable T cell defects have been demonstrated in some patients. It has been hypothesized that hyper-IgE is associated with a Th1/Th2 imbalance. We wished to characterize cytokine and chemokine imbalances that might reflect the underlying disease process or reflect ongoing pathologic processes. Nine patients with hyper-IgE syndrome and six controls were studied. Radioimmunoassays, flow cytometry, and gene array analyses were performed to characterize cytokine and chemokine production. Hyper-IgE patients express more IL-12, while ENA-78, MCP-3, and eotaxin are markedly underexpressed. Underexpression of a set of chemokines could explain a number of features of hyper-IgE syndrome and may offer a new paradigm for the understanding of this disorder.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Cells, Cultured / drug effects
  • Chemokine CCL11
  • Chemokine CCL7
  • Chemokine CXCL5
  • Chemokines / biosynthesis*
  • Chemokines / genetics
  • Chemokines, CC*
  • Chemokines, CXC*
  • Child
  • Child, Preschool
  • Cytokines / biosynthesis*
  • Cytokines / genetics
  • DNA, Complementary / genetics
  • Gene Expression Regulation* / drug effects
  • Humans
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / genetics
  • Interleukin-12 / biosynthesis
  • Interleukin-12 / genetics
  • Interleukin-8 / analogs & derivatives
  • Interleukin-8 / biosynthesis
  • Interleukin-8 / genetics
  • Interleukins / biosynthesis
  • Interleukins / genetics
  • Job Syndrome / genetics
  • Job Syndrome / immunology
  • Job Syndrome / metabolism*
  • Lymphocyte Activation / drug effects
  • Monocyte Chemoattractant Proteins / biosynthesis
  • Monocyte Chemoattractant Proteins / genetics
  • Nicotinamide Phosphoribosyltransferase
  • Osteopontin
  • Phytohemagglutinins / pharmacology
  • RNA, Messenger / biosynthesis
  • Receptor, trkA / biosynthesis
  • Receptor, trkA / genetics
  • Sialoglycoproteins / biosynthesis
  • Sialoglycoproteins / genetics
  • Tetradecanoylphorbol Acetate / pharmacology
  • Th1 Cells / drug effects
  • Th1 Cells / immunology
  • Th2 Cells / drug effects
  • Th2 Cells / immunology
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • CCL11 protein, human
  • CCL7 protein, human
  • CXCL5 protein, human
  • Chemokine CCL11
  • Chemokine CCL7
  • Chemokine CXCL5
  • Chemokines
  • Chemokines, CC
  • Chemokines, CXC
  • Cytokines
  • DNA, Complementary
  • Interleukin-8
  • Interleukins
  • Monocyte Chemoattractant Proteins
  • Phytohemagglutinins
  • RNA, Messenger
  • SPP1 protein, human
  • Sialoglycoproteins
  • Tumor Necrosis Factor-alpha
  • Osteopontin
  • Interleukin-12
  • Interferon-gamma
  • Nicotinamide Phosphoribosyltransferase
  • nicotinamide phosphoribosyltransferase, human
  • Receptor, trkA
  • Tetradecanoylphorbol Acetate